Viewing nowCombinationLosartan/Amlodipine Tablet 5/100 mg
Losartan Potassium 100mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea United Pharmaceutical Co., Ltd.

MFDS item code 201504975 · Approved 2015.07.21 · Insurance code 644308970
Treatment of essential hypertension (uncontrolled with monotherapy · initial therapy for stage 2)
This medication helps control blood pressure in patients with hypertension. It is especially used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or losartan. It is also indicated for patients with stage 2 hypertension who need combination therapy to reach the treatment target blood pressure as an initial therapy. This drug helps to effectively manage blood pressure and prevent cardiovascular complications. It is used for the treatment of hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before administering this medicine; however, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. - 5/50 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams monotherapy. - 5/100 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with the combination product compared with the individual components. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. ○ Patients with reduced intravascular effective circulating volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective circulating volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Older adults: In older adults aged 75 years and older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients starting this medication who have a reduced blood volume may experience hypotension symptoms, so their condition should be carefully assessed before taking the medication. This drug should not be used in individuals with allergic reactions to the active ingredients or similar medications, pregnant or potentially pregnant women, nursing women, patients with severely impaired liver function, patients with certain heart conditions, and those in a state of shock. Caution is advised when prescribing to patients with reduced blood volume, those on a strict salt-restricted diet, patients with severe renal impairment, and patients with hyperkalemia, requiring regular monitoring. Taking this medication may lead to neurological symptoms such as dizziness or headache, and occasionally side effects like drowsiness, palpitations, digestive disorders, and skin rash may occur, so caution is advised. Particularly during hypertension treatment, this medication may cause excessively low blood pressure, so it is advisable to avoid dangerous activities such as working at heights or driving. When taken with other antihypertensive agents, the effect can be potentiated, so it should only be combined after consulting a physician. Taking this drug with grapefruit juice may increase the drug concentration, so co-administration should be avoided. During pregnancy, this drug could affect fetal renal function; therefore, it should not be taken by women planning to become pregnant or who are currently pregnant, and it is also safe to avoid while breastfeeding. Safety and effectiveness have not been established for patients under 18 years of age, hence its use is not recommended in this population. In elderly individuals, particularly those over 75 years of age, initial dose adjustment is necessary, as appropriate dose adjustments may be challenging with this medication. In case of overdose, severe hypotension and impaired cardiac function may occur, necessitating immediate medical attention for proper treatment. This medication should be kept out of reach of children and should not be transferred to other containers to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture exposure, and kept at a cool room temperature between 1 and 30 degrees Celsius. Such storage conditions help maintain the drug's effectiveness over time.
White oval film-coated tablets
Domestic Use - 30 tablets/bottle, Export Use - 30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 100mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea United Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.